Concepedia

Lucas Moreno

LM

1

Publications

29

Citations

1

H-Index

2022

Active since

Affiliations

Rigshospitalet(Current)

Lucas Moreno is an author at Rigshospitalet specializing in cancer therapeutics, cancer research, and medicine.

Top concepts

HealthMedicineOncologyImmunotherapyCancer TherapyCancer ResearchClinical TrialsMolecular OncologyRadiation Oncology

Publications per year

2022–2022

1

Publications

1

BEACON-Immuno: Results of the dinutuximab beta (dB) randomization of the BEACON-Neuroblastoma phase 2 trial—A European Innovative Therapies for Children with Cancer (ITCC–International Society of Paediatric Oncology Europe Neuroblastoma Group (SIOPEN) trial.

Juliet C. Gray, Lucas Moreno, Rebekah Weston et al. · Journal of Clinical Oncology · 2022 · 29 citations

Db Randomisation, Beacon-neuroblastoma Phase 2, Chemo-immunotherapy Randomisation +15

Rows per page

1–1 of 1